Costa Rica vs Europe: Proportion of the target population who received the final dose of
Costa Rica
84.0%
in 2024
Europe
40.0%
in 2024
Costa Rica rank
19th
Europe rank
21st
Proportion of the target population who received the final dose of over time
- Costa Rica
- Europe
How they compare
Costa Rica currently reports 84.0% against 40.0% in Europe, a difference of 44.0%.
That makes Costa Rica's figure about 2.1 times Europe's.
Across all 6 years both countries report, Costa Rica has been ahead every year.
Costa Rica ranks 19th and Europe ranks 21st of 107 countries.
Costa Rica has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Costa Rica | Europe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 96.0% | 36.0% | 60.0% | Costa Rica |
| 2020s | 65.8% | 36.8% | 29.0% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Costa Rica or Europe?
- Costa Rica, at 84.0% against 40.0% in Europe as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Costa Rica and Europe?
- 44.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Europe?
- 6 years are reported by both, from 2019 to 2024.
- How do Costa Rica and Europe rank globally for proportion of the target population who received the final dose of?
- Costa Rica ranks 19th and Europe ranks 21st of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.